Kailera Secures $600M to Advance Dual-Targeting Obesity Drug to Global Phase 3 Tests

Bain Capital Private Equity led Kailera Therapeutics’ Series B financing, which will support global Phase 3 tests of KAI-9531, a weekly injectable drug that hits the same targets as Eli Lilly’s blockbuster obesity medication, Zepbound. The capital will also support development of other oral and injectable metabolic medicines in Kailera’s pipeline. The post Kailera Secures…

Read More

Maybe AI Doesn’t Read Blueprints

By KIM BELLARD Gosh, who knew that Jan 13 would be an AI day, with at least three major announcements about “blueprints” for its development going forward? Of course, these days every day is an AI day; trying to take in all AI-related news can be overwhelming. But before some other AI news drowns them…

Read More

KFF Health News’ ‘What the Health?’: RFK Jr. Upends Vaccine Policy, After Promising He Wouldn’t

The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…

Read More

One Nation, Under Anxiety

Newscasts deliver reports of plane crashes, political turmoil, mass layoffs, rising food prices, and unexpected public health alerts at an increasing pace. In what used to be predictable routines – planning meals, commuting to work, taking kids to school – people across the country now sense an undercurrent of apprehension.  The post One Nation, Under…

Read More